IP Library Granted Patent US 8,660,315
Granted Patent B2
US 8,660,315 · App. 13/766,969 · Granted Feb 25, 2014

Method for administering a drug program to determine whether an animal has been given a drug

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,660,315
App. No.
13/766,969
Granted
Feb 25, 2014
Kind
B2
Abstract

Systems and methods are described that provide a fast and simple way of administering a drug program related to an animal. Specifically, systems are provided that can receive, compile and analyze information regarding the condition of an organ in a form that is readily readable, transferable to others, and associated with, or linked to, other information such as the presence or absence of an administered drug, combination of drugs, or drug program.

Claims (26)

1. A method for determining whether an animal was administered a drug, comprising:

capturing an image of a liver of an animal after the animal has been slaughtered by having said liver scanned within a field of view of a means for generating an image;

associating the image with a lot of origin of the animal;

using a processor, analyzing the image to determine whether the liver indicates that the animal has experienced infection or disease, said analyzing step comprising a review of visual evidence of liver abnormalities;

determining whether the animal was previously administered a drug selected from the group comprising an antibiotic drug, tylosin and a beta receptor agonist;

wherein the step of capturing comprises generating a digital image and said means for generating an image is selected from the group consisting of a digital camera and a digital video camera; and wherein said step of determining comprises correlating an identifying number of an individual animal and said liver.

2. A method for administering a drug program related to an animal, comprising:

receiving a digital image of an organ from an animal depicting the quality or grading of said organ;

determining an animal from which the organ was derived, wherein the animal is a bovine, porcine or ovine animal;

associating the digital image and the determined animal with the presence or absence of a drug or combination of drugs that was previously administered to an animal, said drug selected from the group consisting of tylosin, an antibiotic and a beta receptor agonist;

using a processor, evaluating, by reference to the digital image depicting the organ, whether the determined animal has been treated with the drug or combination of drugs, wherein said evaluating step comprises determining the presence of abnormalities of said organ and wherein the organ is selected from the group consisting of brain, liver, tongue, pancreas gland, thymus gland, stomach, feet, kidney, lungs, heart, small intestine, testicles, placenta, crop and caul;

wherein the digital image is viewable in real time as said organ is passed within a field of view of a means for generating an image; and

wherein said step of determining comprises correlating an identifying number of an individual animal with said organ.

3. A method for administering a drug program related to an animal, comprising:

receiving a digital image of an organ from an animal depicting the quality or grading of said organ;

determining an animal from which the organ was derived, wherein the animal is a bovine, porcine or ovine animal;

associating the digital image and the determined animal with the presence or absence of a drug or combination of drugs that was previously administered to an animal, said drug selected from the group consisting of tylosin, an antibiotic and a beta receptor agonist;

using a processor, evaluating, by reference to the digital image depicting the organ, whether the determined animal has been treated with the drug or combination of drugs, wherein said evaluating step comprises determining the presence of abnormalities of said organ and wherein the organ is selected from the group consisting of brain, liver, tongue, pancreas gland, thymus gland, stomach, feet, kidney, lungs, heart, small intestine, testicles, placenta, crop and caul;

wherein the digital image is viewable in real time as said organ is passed within a field of view of a means for generating an image; and

further comprising generating a report containing information regarding the presence or absence of a drug, combination of drugs, or drug program in the determined animal.

4. The method of claim 2 , wherein the beta receptor agonist drug is selected from the group consisting of racoptamine hydrochloride and zilpaterol hydrochloride.

5. The method of claim 3 , wherein the beta receptor agonist drug is selected from the group consisting of racoptamine hydrochloride and zilpaterol hydrochloride.

6. The method of claim 2 , wherein said digital image is generated by a means for generating an image selected from the group consisting of a digital color camera, a digital black and white camera, and a digital video camera.

7. The method of claim 3 , wherein said digital image is generated by a means for generating an image selected from the group consisting of a digital color camera, a digital black and white camera, and a digital video camera.

8. The method of claim 2 , wherein the combination of drugs elicits an effect that is viewable in said digital image.

9. The method of claim 3 , wherein the combination of drugs elicits an effect that is viewable in said digital image.

Assignments (13)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 047223, FRAME 0689 Recorded Nov 1, 2022
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: JBS USA FOOD COMPANY; SKIPPACK CREEK CORPORATION; SWIFT BEEF COMPANY; SWIFT BRANDS COMPANY
Reel/Frame 061835/0712 →
RELEASE OF SECURITY INTEREST Recorded Sep 27, 2022
From: BARCLAYS BANK PLC
To: JBS USA LUX S.A. (F/K/A JBS USA, LLC); SWIFT BEEF COMPANY; SKIPPACK CREEK COMPANY
Reel/Frame 061546/0289 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Oct 12, 2018
From: JBS USA FOOD COMPANY; SKIPPACK CREEK CORPORATION; SWIFT BEEF COMPANY; SWIFT BRANDS COMPANY
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 047223/0689 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 12, 2018
From: BANK OF AMERICA, N.A.
To: JBS USA LUX S.A.
Reel/Frame 047649/0711 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE DUPLICATE APPLICATION NUMBER 12575964 PREVIOUSLY RECORDED ON REEL 042069 FRAME 001. ASSIGNOR(S) HEREBY CONFIRMS THE SUCCESSOR AGENT AGREEMENT. Recorded Apr 28, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: BARCLAYS BANK PLC, AS ADMINISTRATIVE AGENT
Reel/Frame 042362/0227 →
SUCCESSOR AGENT AGREEMENT Recorded Mar 22, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: BARCLAYS BANK PLC, AS ADMINISTRATIVE AGENT
Reel/Frame 042069/0001 →
SECURITY INTEREST Recorded Jan 7, 2016
From: JBS USA FOOD COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 037429/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: JBS USA, LLC
To: JBS ANSEMBOURG HOLDING S.A.R.L.
Reel/Frame 037364/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: JBS ANSEMBOURG HOLDING S.A.R.L.
To: JBS LUXEMBOURG S.A.R.L.
Reel/Frame 037365/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: JBS LUXEMBOURG S.A.R.L.
To: JBS USA FOOD COMPANY HOLDINGS
Reel/Frame 037365/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: JBS USA FOOD COMPANY HOLDINGS
To: JBS USA FOOD COMPANY
Reel/Frame 037365/0467 →
SECURITY INTEREST Recorded Oct 30, 2014
From: JBS USA, LLC
To: BANK OF AMERICA, N. A., AS ADMINISTRATIVE AGENT
Reel/Frame 034089/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2013
From: MIRTSCHING, WARREN; FELIX, JOHN; GUSTAFSON, MARK A.
To: JBS USA, LLC
Reel/Frame 029811/0790 →